- Home
- VMD vs RCKT Comparison
VMD vs RCKT Comparison
Compare VMD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMD
- RCKT
- Stock Information
- Founded
- VMD 2006
- RCKT 1999
- Country
- VMD United States
- RCKT United States
- Employees
- VMD N/A
- RCKT N/A
- Industry
- VMD
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- VMD
- RCKT Health Care
- Exchange
- VMD Nasdaq
- RCKT Nasdaq
- Market Cap
- VMD 279.4M
- RCKT 326.4M
- IPO Year
- VMD N/A
- RCKT N/A
- Fundamental
- Price
- VMD $6.62
- RCKT $2.70
- Analyst Decision
- VMD
- RCKT Buy
- Analyst Count
- VMD 0
- RCKT 13
- Target Price
- VMD N/A
- RCKT $18.50
- AVG Volume (30 Days)
- VMD 143.6K
- RCKT 8.4M
- Earning Date
- VMD 08-06-2025
- RCKT 08-04-2025
- Dividend Yield
- VMD N/A
- RCKT N/A
- EPS Growth
- VMD 19.95
- RCKT N/A
- EPS
- VMD 0.30
- RCKT N/A
- Revenue
- VMD $232,793,000.00
- RCKT N/A
- Revenue This Year
- VMD $17.35
- RCKT N/A
- Revenue Next Year
- VMD $12.87
- RCKT N/A
- P/E Ratio
- VMD $22.10
- RCKT N/A
- Revenue Growth
- VMD 19.97
- RCKT N/A
- 52 Week Low
- VMD $6.14
- RCKT $2.19
- 52 Week High
- VMD $9.81
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- VMD 46.22
- RCKT 32.09
- Support Level
- VMD $6.56
- RCKT $2.66
- Resistance Level
- VMD $6.84
- RCKT $3.33
- Average True Range (ATR)
- VMD 0.22
- RCKT 0.28
- MACD
- VMD -0.00
- RCKT 0.09
- Stochastic Oscillator
- VMD 15.07
- RCKT 26.59
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.